全文获取类型
收费全文 | 2381篇 |
免费 | 126篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 89篇 |
儿科学 | 32篇 |
妇产科学 | 53篇 |
基础医学 | 339篇 |
口腔科学 | 45篇 |
临床医学 | 189篇 |
内科学 | 314篇 |
皮肤病学 | 137篇 |
神经病学 | 245篇 |
特种医学 | 221篇 |
外科学 | 295篇 |
综合类 | 15篇 |
预防医学 | 83篇 |
眼科学 | 71篇 |
药学 | 152篇 |
中国医学 | 12篇 |
肿瘤学 | 247篇 |
出版年
2023年 | 15篇 |
2022年 | 45篇 |
2021年 | 47篇 |
2020年 | 23篇 |
2019年 | 59篇 |
2018年 | 46篇 |
2017年 | 65篇 |
2016年 | 70篇 |
2015年 | 119篇 |
2014年 | 112篇 |
2013年 | 136篇 |
2012年 | 161篇 |
2011年 | 174篇 |
2010年 | 98篇 |
2009年 | 112篇 |
2008年 | 146篇 |
2007年 | 125篇 |
2006年 | 127篇 |
2005年 | 107篇 |
2004年 | 85篇 |
2003年 | 59篇 |
2002年 | 46篇 |
2001年 | 42篇 |
2000年 | 50篇 |
1999年 | 36篇 |
1998年 | 41篇 |
1997年 | 26篇 |
1996年 | 31篇 |
1995年 | 19篇 |
1994年 | 27篇 |
1993年 | 18篇 |
1992年 | 16篇 |
1991年 | 20篇 |
1990年 | 26篇 |
1989年 | 31篇 |
1988年 | 36篇 |
1987年 | 17篇 |
1986年 | 18篇 |
1985年 | 15篇 |
1984年 | 12篇 |
1983年 | 9篇 |
1982年 | 9篇 |
1981年 | 6篇 |
1980年 | 12篇 |
1979年 | 6篇 |
1977年 | 8篇 |
1976年 | 6篇 |
1975年 | 3篇 |
1974年 | 6篇 |
1973年 | 8篇 |
排序方式: 共有2539条查询结果,搜索用时 0 毫秒
31.
Jae Eun Roh Sang-Hoon Cha Seung Young Lee Min Hee Jeon Bum Sang Cho Min Ho Kang Kyung Soo Min 《Korean journal of radiology》2012,13(1):107-110
We present a case of developmental venous anomaly associated with arteriovenous fistula supplied by a single arterial feeder adjacent to a large acute intracerebral hemorrhage. The arteriovenous fistula was successfully obliterated by superselective embolization while completely preserving the developmental venous anomaly. Two similar cases, including superselective angiographic findings, have been reported in the literature; however, we describe herein superselective angiographic findings in more detail and demonstrate the arteriovenous shunt more clearly than the previous reports. In addition, a literature review was performed to discuss the association of a developmental venous anomaly with vascular lesions. 相似文献
32.
33.
Jeong-Min Kim Keun-Hwa Jung Kee Hong Park Soon-Tae Lee Kon Chu Jae-Kyu Roh 《Journal of neuro-oncology》2013,111(3):295-301
Cancer related stroke may have different phenotypes from non-cancer stroke, especially in terms of stroke progression and recurrence. We performed a case–control study to identify their incidences and risk factors in cancer related stroke. Between January 2001 and December 2009, we conducted a retrospective review of acute ischemic stroke patients with cancer who were admitted to Seoul National University Hospital, Seoul, Korea. The stroke patients without cancer served as control. We collected demographic variables, vascular risk factors, stroke phenotype, clinical course, and cancer information including diagnosis, stage, and treatment status. Among cancer stroke patients, the potential risk factor of stroke recurrence was evaluated. The mean age of the 102 cancer patients was 66.4 ± 10.8 years, and 64.7 % were men. The mean time interval from cancer diagnosis to stroke onset was 39.7 ± 60.9 months. The principal lesion pattern of cancer stroke was multiple dots extending single vascular territory (39.2 %), and they were associated with low hemoglobin and high fibrinogen levels. Stroke progression and recurrence were noted in 9.8 and 27.5 % of cancer stroke patients, and in 9.3 and 12.7 % of control patients, respectively. The stroke subtype was independently associated with recurrence of cancer stroke after multiple logistic regression (odds ratio = 3.165, 95 % confidence interval = 1.080–9.277, p = 0.036). Cancer related stroke has a distinct phenotype in terms of infarction pattern and laboratory findings. Stroke recurrence is frequently observed among cancer stroke patients, and its risk is related with stroke subtype. 相似文献
34.
Young Hak Roh MD Ki Woong Kim MD Nam-Jong Paik MD Tae Kyun Kim MD Hyun Sik Gong MD 《Clinical orthopaedics and related research》2012,470(11):3246-3252
Background
Musculoskeletal complaints influence general health status, but the relative contribution of concurrent upper and lower extremity disabilities on patient perceptions of general health is unclear. 相似文献35.
36.
Home therapy with porcine factor VIIIC was safe and effective when administered to five hemophilic patients over periods of 8 1/2, 6, 4, 3 1/2, and 2 years. No significant transfusion reactions occurred. Before treatment with porcine factor VIIIC, all five had high-level, high- responding anti-human VIIIC inhibitors initially lacking anti-porcine factor VIIIC activity. Although specific anti-porcine VIIIC inhibitors arose in all patients, these were generally transient, and only one patient became refractory to treatment. We believe that porcine factor VIIIC is the treatment of choice in patients whose inhibitors do not cross-react. All five patients lost their original anti-human VIIIC inhibitors after starting treatment with porcine VIIIC, permitting the reintroduction of human VIIIC in three of them. There has been no recurrence of anti-human VIIIC inhibitor activity during 2 to 3 years of regular treatment with human VIIIC in these patients. This suggests that tolerance to human VIIIC has arisen as a result of treatment with porcine VIIIC. Porcine VIIIC may have a role in the desensitization of some factor VIIIC inhibitor patients. 相似文献
37.
Carrier detection in hemophilia A: a cooperative international study. I. The carrier phenotype 总被引:1,自引:0,他引:1
Graham JB; Rizza CR; Chediak J; Mannucci PM; Briet E; Ljung R; Kasper CK; Essien EM; Green PP 《Blood》1986,67(6):1554-1559
Eight laboratories in six countries cooperated to clarify several issues concerning the phenotypes of heterozygous carriers of hemophilia "A." Plasma levels of factor VIII (F.VIII:C, formerly VIII:C) and von Willebrand factor (VWF:Ag, formerly VIIIR:Ag) of carriers and normal women were determined by various "in-house" methods; a single lyophilized plasma standard was used for all assays. Analysis of the collated data from 336 carriers (296 obligatory carriers and 40 sporadic carriers) and 137 normal women showed that there was no difference in the F.VIII:C levels of "paternal" carriers (women who had obtained the abnormal gene from their fathers) and "maternal" carriers. Neither was there a difference in the VWF:Ag levels of normal women and either type of carrier. Age was found to have a significant effect on both F.VIII:C and VWF:Ag, values being higher at very young and very old ages, the minima occurring in the 25- to 30-year range. ABO blood type had a striking effect. Women of types A, B, and AB (designated non- O in the study), both normals and carriers, had significantly higher levels of both factors than did women of type O. Analysis by laboratories showed that differences in mean levels of both factors between laboratories were highly significant. It was concluded that age, ABO blood type, and laboratory variation should be taken into account in carrier detection. 相似文献
38.
Kyung Eun Kim Hwajin Kim Rok Won Heo Hyun Joo Shin Chin-ok Yi Dong Hoon Lee Hyun Joon Kim Sang Soo Kang Gyeong Jae Cho Wan Sung Choi Gu Seob Roh 《The Korean journal of physiology & pharmacology》2015,19(5):451-460
Sirtuin 1 (SIRT1) is a mammalian NAD+-dependent protein deacetylase that regulates cellular metabolism and inflammatory response. The organ-specific deletion of SIRT1 induces local inflammation and insulin resistance in dietary and genetic obesity. Macrophage-mediated inflammation contributes to insulin resistance and metabolic syndrome, however, the macrophage-specific SIRT1 function in the context of obesity is largely unknown. C57/BL6 wild type (WT) or myeloid-specific SIRT1 knockout (KO) mice were fed a high-fat diet (HFD) or normal diet (ND) for 12 weeks. Metabolic parameters and markers of hepatic steatosis and inflammation in liver were compared in WT and KO mice. SIRT1 deletion enhanced HFD-induced changes on body and liver weight gain, and increased glucose and insulin resistance. In liver, SIRT1 deletion increased the acetylation, and enhanced HFD-induced nuclear translocation of nuclear factor kappa B (NF-κB), hepatic inflammation and macrophage infiltration. HFD-fed KO mice showed severe hepatic steatosis by activating lipogenic pathway through sterol regulatory element-binding protein 1 (SREBP-1), and hepatic fibrogenesis, as indicated by induction of connective tissue growth factor (CTGF), alpha-smooth muscle actin (α-SMA), and collagen secretion. Myeloid-specific deletion of SIRT1 stimulates obesity-induced inflammation and increases the risk of hepatic fibrosis. Targeted induction of macrophage SIRT1 may be a good therapy for alleviating inflammation-associated metabolic syndrome. 相似文献
39.
40.
Kim JC Koo KH Lee DH Roh SA Kim HC Yu CS Kang GH 《International journal of colorectal disease》2001,16(2):102-107
Although the APC protein is known to participate in cellular proliferation and apoptosis, APC mutations have been thought to play a major role in the early stage of colorectal tumorigenesis. The somatic APC mutation of exon 15 was assessed to determine its impact on various stages of colorectal tumorigenesis. The colorectal neoplastic tissues of serial array studied included sporadic adenomas (group 1, n = 36), adenomas (group 2, n = 33), and carcinomas (group 3, n = 32) in the synchronous adenoma and carcinoma as well as sporadic carcinomas (group 4, n = 36). Aberrant DNA was detected by protein truncation test and confirmed by direct sequencing. The mutation prevalence was 36.1% in group 1, 45.5% in group 2, 59.4% in group 3, and 41.7% in group 4 with no differences among the groups. Among the 18 patients with synchronous adenoma and carcinoma, 9 had mutation in their adenomas and 12 in their carcinomas. The mutation loci and patterns did not differ in adenomas and carcinomas. Mutations in the mutation cluster region (MCR) were much more frequent than in the preceding region of MCR, i.e., 85.7% vs. 14.3%. The mutation prevalence of villous adenomas appeared greater than that of tubular adenoma (3/21 vs. 3/4). Predominant pathogenic mutations at MCR suggest that the APC mutation is implicated in all stages of colorectal tumorigenesis. 相似文献